Journal list Promote Sponsor
verified SJR 0,114 · Q4
Clinical Schizophrenia and Related Psychoses
United States · Walsh Medical Media, LLC
workspace_premium Q4 — Medicine (miscellaneous) lock Subscription

Clinical Schizophrenia and Related Psychoses

Clinical Schizophrenia and Related Psychoses is a journal indexed in SJR in Medicine (miscellaneous) and Psychiatry and Mental Health with an H index of 27. It has an SJR impact factor of 0,114 and it has a best quartile of Q4. It has an SJR impact factor of 0,114.

ISSN: 1935-1232
Publisher: Walsh Medical Media, LLC
Category: Medicine (miscellaneous)
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,114 Q4
H-index 27
Acceptance rate pie_chart
37%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

0,114

H-index

27

Docs (year)

21

Docs 3y

115

Total refs

510

Cites 3y

57

Citable 3y

107

Cites/Doc 2y

0.44

Ref/Doc

24.29

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antipsychotics for patients with Wolff-Parkinson-White Syndrome

View more

Why Not Clozapine?

View more

Clinical News

View more

Clinical News

View more

Clinical News

View more

Clinical News

View more

Clinical Correlates of Initial Treatment Disengagement in First-Episode Psychosis

View more

Clients' Perceptions of Effective Supports in Vocational Rehabilitation

View more

Childhood Stressors and Symptoms of Schizophrenia

View more

Can Transcranial Direct Current Stimulation Improve Cognitive Functioning in Adults with Schizophrenia?

View more

Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device

View more

Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia

View more
SHOW MORE ARTICLES

Assessing Intimidation Using a Brief Intrusiveness Measure

View more

A Brief Review of a Brain Model for Schizophrenia and Other Psychotic Disorders Which Might Suggest Novel Treatment Modalities

View more

Antipsychotic Combination with Psychosocial Intervention on Outcome of Schizophrenia (ACPIOS): Rationale and Design of the Clinical Trial

View more

Anhedonia of Patients with Schizophrenia and Schizoaffective Disorder is Attributed to Personality-Related Factors Rather than to State-Dependent Clinical Symptoms

View more

An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis

View more

Amelioration of Negative Symptoms in Schizophrenia by Escitalopram: A Double-Blind, Placebo-Controlled Clinical Trial

View more

All Psychosis is Not Schizophrenia, Especially Not in Women

View more

Advantages and Limitations of Newer Antipsychotics

View more

Add-On Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial

View more

A Review of Diffusion Tensor Imaging in Schizophrenia

View more

A Pilot Study to Determine a Prolactin Threshold that Identifies Improved Sexual Functioning when Switching from a Prolactin-Elevating to a Prolactin-Neutral Antipsychotic

View more

A Pilot Study of Cultural/Racial Differences in Patient Perspectives on Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia

View more

FAQs